Jamieson Wellness, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA4707481046
CAD
34.07
0.16 (0.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Jamieson Wellness, Inc. stock-summary
stock-summary
Jamieson Wellness, Inc.
Pharmaceuticals & Biotechnology
Jamieson Wellness Inc is a Canada-based company, which operates as the health and wellness company. The Company develops, manufactures and markets brand of vitamins and natural health products. The Company offers vitamins, minerals and supplements (VMS) products and certain over-the-counter remedies through Jamieson and LVHS brands, as well as sports nutrition products through Progressive, Precision and Iron Vegan brands. The Company offers manufacturing and product development services on a contract manufacturing basis to select blue-chip consumer health companies and retailers worldwide. Additionally, the Company also offers services to Strategic Partners Business customers, including regulatory advice, new product development and distribution services and industry insights.
Company Coordinates stock-summary
Company Details
1 Adelaide Street East, Suite 2200 , TORONTO CA : M5C 2V9
stock-summary
Tel: 1 416 96000521 416 7055437
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 1 Schemes (0.06%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. David Williams
Independent Chairman of the Board
Mr. Mark Hornick
President, Chief Executive Officer, Director
Ms. Heather Allen
Independent Director
Dr. Louis Aronne
Independent Director
Mr. Timothy Penner
Independent Director
Catherine Potechin
Independent Director
Mr. Steven Spooner
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
199 Million
(Quarterly Results - Jun 2025)
Net Profit:
14 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 1,461 Million (Small Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.82

stock-summary
Return on Equity

10.50%

stock-summary
Price to Book

3.12